Adaptive Biotechnologies Corporation ADPT

$ 4.67 6.75%

Quarterly report 2024-Q3
added 11-07-2024

Adaptive Biotechnologies Corporation Financial Statements 2011-2024 | ADPT

Annual Financial Statements Adaptive Biotechnologies Corporation

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	596 M	1.23 B	2.03 B	7.42 B	2.13 B	-	-	-	-	-	-	-	-
Shares	144 M	143 M	140 M	131 M	69.2 M	-	-	-	-	-	-	-	-
Historical Prices	4.13	8.61	14.4	56.6	28.1	-	-	-	-	-	-	-	-
Net Income	-225 M	-200 M	-207 M	-146 M	-68.6 M	-46.4 M	-42.8 M	-	-	-	-	-	-
Revenue	170 M	185 M	154 M	98.4 M	85.1 M	55.7 M	38.4 M	-	-	-	-	-	-
Cost of Revenue	75.6 M	57.9 M	49.3 M	22.5 M	22.3 M	19.7 M	15.7 M	-	-	-	-	-	-
Gross Profit	-	-	-	-	62.8 M	36 M	22.8 M	-	-	-	-	-	-
Operating Income	-227 M	-200 M	-209 M	-153 M	-78.4 M	-49.8 M	-44.5 M	-	-	-	-	-	-
Interest Expense	13.8 M	4.24 M	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-207 M	-181 M	-197 M	-146 M	-76.7 M	-48.1 M	-41.9 M	-	-	-	-	-	-
Operating Expenses	-	-	-	-	141 M	85.8 M	66.4 M	-	-	-	-	-	-
General and Administrative Expenses	83.9 M	88.5 M	74.5 M	49.5 M	30.3 M	20.4 M	15.9 M	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Adaptive Biotechnologies Corporation

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	148 M	147 M	146 M	145 M	145 M	144 M	144 M	143 M	143 M	142 M	142 M	141 M	141 M	140 M	139 M	138 M	134 M	127 M	126 M	125 M	124 M	13.3 M	12.9 M	12.8 M	12.6 M	12.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-32.1 M	-46.2 M	-47.5 M	-	-50.3 M	-47.8 M	-57.7 M	-	-45.3 M	-52 M	-62.7 M	-	-55.9 M	-56 M	-40.6 M	-	-36.7 M	-33.5 M	-31.4 M	-	-14 M	-15.7 M	-18.4 M	-	-8.29 M	-12.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	46.4 M	43.2 M	41.9 M	-	37.9 M	48.9 M	37.6 M	-	47.8 M	43.7 M	38.6 M	-	39.5 M	38.5 M	38.4 M	-	26.3 M	21 M	20.9 M	-	26.1 M	22.1 M	12.7 M	-	17.2 M	11.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	16.7 M	19.3 M	18.1 M	-	19.3 M	17.9 M	18.7 M	-	14.9 M	13.2 M	13.2 M	-	14.2 M	10.8 M	9.99 M	-	6.05 M	4.91 M	5.34 M	-	5.6 M	5.73 M	4.99 M	-	5.36 M	5.04 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-32.6 M	-47.3 M	-48.8 M	-	-51 M	-47.8 M	-57.2 M	-	-45.4 M	-52.5 M	-63.1 M	-	-56.3 M	-49.8 M	-41.3 M	-	-37 M	-36.9 M	-34.6 M	-	-18.1 M	-16.1 M	-20 M	-	-9.16 M	-13.3 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	2.94 M	2.7 M	2.99 M	-	3.65 M	3.6 M	3.53 M	-	653 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-28 M	-42.3 M	-43.5 M	-	-45.2 M	-42.2 M	-51.8 M	-	-45 M	-52.1 M	-58.4 M	-	-48.5 M	-49.3 M	-39 M	-	-32.2 M	-33.8 M	-33.1 M	-	-13.6 M	-13.3 M	-18.7 M	-	-6.02 M	-11.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	17.3 M	17.9 M	19.6 M	-	20.1 M	22.3 M	20.8 M	-	20.8 M	21.2 M	24.1 M	-	20.2 M	16.1 M	14.9 M	-	12.1 M	12.2 M	11.8 M	-	8.48 M	6.66 M	7 M	-	4.74 M	4.63 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency